Loss of annexin A1 expression in breast cancer progression

Applied Immunohistochemistry and Molecular Morphology

Volumn 16, Issue 6, 2008, Pages 530-534

  Cao, Ying ^a   Li, Yong ^a   Edelweiss, Marcia ^a   Arun, Banu ^a   Rosen, Daniel ^a   Resetkova, Erika ^a   Wu, Yun ^a   Liu, Jinsong ^a   Sahin, Aysegul ^a   Albarracin, Constance T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

ANXA1; Breast carcinoma; Breast carcinoma in situ

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; LIPOCORTIN 1; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CARCINOMA IN SITU; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE SECTION; BIOSYNTHESIS; BREAST TUMOR; CELL TRANSFORMATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY;

ANNEXIN A1; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 67650287281     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31817432c3     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Ma XJ, Salunga R, Tuggle JT, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA. 2003;13: 5974-5979. (Pubitemid 36576916)
3. Beckmann MW, Niederacher D, Schnü rch HG, et al. Multistep carcinogenesis of breast cancer and tumour heterogeneity. J Mol Med. 1997;75:429-439.
4. Solito E, de Coupade C, Canaider S, et al. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol. 2001;133:217-228. (Pubitemid 32514504)
5. Perretti M, Flower RJ. Annexin 1 and the biology of the neutrophil. J Leukoc Biol. 2004;76:25-29.
6. Perretti M. The annexin 1 receptor(s): is the plot unravelling? Trends Pharmacol Sci. 2003;24:574-579.
7. Ahn SH, Sawada H, Ro JY, et al. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin Exp Metastasis. 1997;15:151-156. (Pubitemid 27157817)
8. Pepinsky RB. Phosphorylation of lipocortin-1 by the epidermal growth factor receptor. Methods Enzymol. 1991;198:260-272.
9. Sakamoto T, Repasky WT, Uchida K, et al. Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun. 1996; 220:643-647. (Pubitemid 26198565)
10. de Coupade C, Solito E, Levine JD. Dexamethasone enhances interaction of endogenous annexin 1 with L-selectin and triggers shedding of L-selectin in the monocytic cell line U-937. Br J Pharmacol. 2003;140:133-145. (Pubitemid 37175839)
11. Bai XF, Ni XG, Zhao P, et al. Overexpression of annexin 1 in pancreatic cancer and its clinical significance. World J Gastroenterol. 2004;10:1466-1470. (Pubitemid 39206812)
12. Masaki T, Tokuda M, Ohnishi M, et al. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma. Hepatology. 1996;24:72-81. (Pubitemid 26249416)
13. Johnson MD, Kamso-Pratt J, Pepinsky RB, et al. Lipocortin-1 immunoreactivity in central and peripheral nervous system glial tumors. Hum Pathol. 1989;20:772-776. (Pubitemid 19203639)
14. Sinha P, Hutter G, Kottgen E, et al. Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. J Biochem Biophys Methods. 1998;37:105-116. (Pubitemid 28517927)
15. Xin W, Rhodes DR, Ingold C, et al. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol. 2003;162:255-261. (Pubitemid 36042007)
16. Hu N, Flaig MJ, Su H, et al. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma. Clin Cancer Res. 2004;10:6013-6022. (Pubitemid 39302608)
17. Pencil SD, Toh Y, Nicolson GL. Candidate metastasis-associated genes of the rat 13762NF mammary adenocarcinoma. Breast Cancer Res Treat. 1993;25:165-174. (Pubitemid 23170615)
18. Pencil SD, Toth M. Elevated levels of annexin I protein in vitro and in vivo in rat and human mammary adenocarcinoma. Clin Exp Metastasis. 1998;16:113-121. (Pubitemid 28252918)
19. Schwartz-Albiez R, Koretz K, Moller P, et al. Differential expression of annexins I and II in normal and malignant human mammary epithelial cells. Differentiation. 1993;52:229-237. (Pubitemid 23096125)
20. Shen D, Chang HR, Chen Z, et al. Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. Biochem Biophys Res Commun. 2005;326:218-227. (Pubitemid 39573222)
21. Shen D, Nooraie F, Elshimali Y, et al. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol. 2006;37:1583-1591. (Pubitemid 44792225)
22. Toh Y, Pencil SD, Nicolson GL. Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene. 1995;159:97-104.
23. Middleton LP, Vlastos G, Mirza NQ, et al. Multicentric mammary carcinoma: evidence of monoclonal proliferation. Cancer. 2002;94: 1910-1916. (Pubitemid 34270042)
24. Wang KL, Wu TT, Choi IS, et al. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007;15: 658-667.
25. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966-978.
26. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol. 2001;19: 3817-3827.
27. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474-1481.
28. Kawase K, Hu YX, Liu J, et al. Potential role of annexin A1 (ANXA1) as a growth inhibitor in breast cancer cell lines. Annual meeting. Proceedings of the American Association for Cancer Research. 2005;3674.
29. Speer R, Calvert VS, Wulfkuhle JD, et al. A reevaluation of annexin I expression in normal breast and breast carcinoma. Annual meeting. Proceedings of the American Association for Cancer Research. 2005;3674.
30. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331-371.
31. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.